<DOC>
	<DOCNO>NCT00947037</DOCNO>
	<brief_summary>An extension study IN 09 004 test long term safety Accordion Pill Carbidopa/Levodopa ( AP-CD/LD )</brief_summary>
	<brief_title>Gastric Retentive Carbidopa/ Levodopa Parkinson 's Patients ; One Year , Open Label , Safety Extension Study</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Subject satisfactorily complete study IN 09 004 , opinion investigator , benefit participation extension study Subject Parkinson 's disease experience predictable motor fluctuation , end dose `` wearing '' , define patient 's report least two episode daily decline function peak benefit , least 2 hour OFF day discretion PI ( include early morning akinesia nocturnal akinesia ) Subject treat least 3 month prior study 5001000 mg Levodopa + DDCI , 4 divide dos per day Hoehn Yahr stag IIII Subjects must able adhere visit schedule protocol requirement available complete study Prepared able give write ( sign date ) inform consent , include compliance study requirement restriction prior admission study . Exclusion Criteria Subject undergone Deep brain stimulation ( DBS ) neurological surgical procedure affect neurological symptom ( e.g tremor , rigidity , stiffness , slow movement , walk problem ) Subjects gastrointestinal surgery appendectomy herniotomy , recent history inflammatory bowel disease , irritable bowel syndrome , severe gastrointestinal narrowing , intestinal obstruction , frequent nausea emesis diarrhea , opinion investigator , contraindicate his/her participation Subjects recent history clinically define GERD , peptic ulcer gastrointestinal disorder likely influence drug absorption , opinion investigator , contraindicate his/her participation</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>